Obesity drug Wegovy cut risk of serious heart problems by 20%, study finds
Obesity drug Wegovy cut risk of serious heart problems by 20%, study finds

Obesity drug Wegovy cut risk of serious heart problems by 20%, study finds

The popular weight-loss drug Wegovy reduced the risk of serious heart problems by 20% in a large, international study that experts say could change the way doctors treat certain heart patients.
The research is the first to document that an obesity medication can not only pare pounds, but also safely prevent a heart attack, stroke or a heart-related death in people who already have heart disease — but not diabetes.
The findings could shift perceptions that the new class of obesity drugs are cosmetic treatments and put pressure on health insurers to cover them.
So your belief is that nobody who plays sports ever dies of heart disease? Yeah, no. Heart disease can be reduced through exercise (but never cut by 100%—that part of your post is just flat-out wrong). At times it can also be worsened by it—see the marathon runners who drop dead partway through the race.
The drug in question also isn’t a pill, but that’s the least part of your medical ignorance.